Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,913,464
-
Share change
-
+2,609,364
-
Total reported value
-
$1,047,948,698
-
Price per share
-
$29.18
-
Number of holders
-
109
-
Value change
-
+$80,679,718
-
Number of buys
-
62
-
Number of sells
-
39
Institutional Holders of PORTOLA PHARMACEUTICALS INC - COM (PTLA) as of Q2 2014
As of 30 Jun 2014,
PORTOLA PHARMACEUTICALS INC - COM (PTLA) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,913,464 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT CO LLP, FMR LLC, Temasek Holdings (Private) Ltd, FRANKLIN RESOURCES INC, EAGLE ASSET MANAGEMENT INC, Sectoral Asset Management Inc, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, JPMORGAN CHASE & CO, and BlackRock Fund Advisors.
This page lists
109
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.